𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development and preclinical evaluation of a new F(ab′)2 antitoxin against botulinum neurotoxin serotype A

✍ Scribed by Yun-Zhou Yu; Shu-Ming Zhang; Wen-Bing Wang; Yun Du; Heng-Qi Zhu; Rui-Lin Wang; Xiao-Wei Zhou; Jian-Bo Lin; Shuang Wang; Wei-Yuan Yu; Pei-Tang Huang; Zhi-Wei Sun

Book ID
116309267
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
201 KB
Volume
92
Category
Article
ISSN
0300-9084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monoclonal antibodies to placental alkal
Monoclonal antibodies to placental alkaline phosphatase: Preclinical evaluation in a human xenograft tumour model of F(ab')2 and Fab fragments
✍ H. Durbin; E. M. Milligan; S. J. Mather; D. F. Tucker; R. Raymond; W. F. Bodmer 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 531 KB

Six new placental alkaline phosphatase monoclonal antibodies (MAbs) have been evaluated in order to select a potentially clinically useful antibody fragment for use in immunoxintigraphy or therapy. Initially, 3 antibodies were identified by trial pepsin digestion as likely to give satisfactory F(ab'

Evaluation of chemical degradation of a
Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry
✍ Tia Estey; Christina Vessely; Theodore W. Randolph; Ian Henderson; LaToya Jones 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB

Vaccines utilizing recombinant protein antigens typically require an adjuvant to enhance immune response in the recipients. However, the consequences of antigen binding to adjuvant on both the short-and long-term stability of the protein remain poorly defined. In our companion paper (Vessely et al.,